Antiflu Des Capsule
NDC Package 82688-001-12
Package Information
Antiflu Des (acetaminophen phenylephrine hcl chlorpheniramine maleate) capsules is ▪ Do not take more than recommended dose Adults and children 12 years of age and over: take 1 capsule with water every 4 hours. This formulation utilizes a capsule delivery system. Marketed by Productos Farmaceuticos, S.a. De C.v., this product is identified by NDC 82688-001 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 2599517 - acetaminophen 325 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG Oral Capsule
- RxCUI: 2599517 - acetaminophen 325 MG / chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 10 MG Oral Capsule
- RxCUI: 2599517 - APAP 325 MG / chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 10 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 82688 - Productos Farmaceuticos, S.a. De C.v.
- 82688-001 - Antiflu Des
- 82688-001-12 - 1 BLISTER PACK in 1 CARTON / 12 CAPSULE in 1 BLISTER PACK
- 82688-001 - Antiflu Des
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 82688-001-12 identifies a specific commercial package of 1 blister pack in 1 carton / 12 capsule in 1 blister pack of Antiflu Des Cough And Flu, a human over the counter drug labeled by Productos Farmaceuticos, S.a. De C.v.. This capsule is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Productos Farmaceuticos, S.a. De C.v. on April 15, 2022. The current certification is valid through December 31, 2026.
How is this Productos Farmaceuticos, S.a. De C.v. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 82688000112. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.